Cablevision's support of The Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $110 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2008 Research Grants

Canary Foundation
Brad Nelson, Ph.D.
The Pancreatic Cancer Biomarker Initiative

Dana-Farber Cancer Institute
James DeCaprio, M.D.
The Pancreatic Cancer Biomarker Initiative

Johns Hopkins University
Nita Ahuja, M.D.
Aberrant Hypermethylation of CpG Island Promoters in Pancreatic Cancer: Constructing a Hypermethylome

University of California, San Francisco
Allan Balmain, Ph.D.
Therapeutic Approaches to Pancreatic Cancer Based on K-Ras Isoform 4A Expression in Stem Cells

University of California, San Francisco
James Marks, Ph.D.
The Pancreatic Cancer Biomarker Initiative

Fred Hutchinson Cancer Research Center
Sunil R. Hingorani, M.D., Ph.D.
Oncogenic K-Ras as a Therapeutic Target for Pancreas Cancer

Johns Hopkins University
Allison Klein, Ph.D.
Identification of Pancreatic Cancer Susceptibility Genes

University of Michigan Medical School
Chandan Kumar, Ph.D.
Discovery of Recurrent Gene Fusions in Pancreatic Cancer using High-Throughput Sequencing

Johns Hopkins University School of Medicine
Joshua Mendell, M.D., Ph.D.
Ras-regulated microRNAs in Pancreatic Cancer

Massachusetts General Hospital
Jeffrey Settleman, Ph.D.
Identification and Validation of Novel Therapeutics Targets for K-Ras-mutant Pancreatic Cancer

Ohio State University
Thomas D. Schmittgen, Ph.D.
MicroRNA Profiling in Serum of Pancreatic Adenocarcinoma Patients
*Supported by a generous donation from the Michael Rolfe Pancreatic Cancer Foundation

Van Adel Research Institute
Brian Cao, M.D.
The Pancreatic Cancer Biomarker Initiative

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303